EX-99.1 2 e35345ex99_1.htm PRESS RELEASE

EXHIBIT 99.1

FOR IMMEDIATE RELEASE

CIT DECLARES PREFERRED SERIES C AND SERIES D DIVIDENDS

        NEW YORK – May 6, 2009 – CIT Group Inc. (NYSE: CIT), a leading provider of financing to small businesses and middle market companies, today announced that its Board of Directors declared quarterly cash dividends on certain of its outstanding preferred stock:

s Series C preferred stock - $1.093750 per share payable June 15, 2009, to holders of record at the close of business May 29, 2009.
s Series D preferred stock - $12.500000 per share payable May 15, 2009 to holders of record at the close of business April 30, 2009.

        CIT management intends to recommend that the Board of Directors declare the Series A and Series B preferred dividends payable June 15, 2009, subject to successful execution of the Alternate Payment Mechanism, which requires the sale of common stock in an amount sufficient to cover such dividends.

EDITOR’S NOTE:

Individuals interested in receiving corporate news releases can register at http://newsalerts.cit.com or subscribe to the RSS feed at http://rss.cit.com. In addition, CIT podcasts are available at www.5minutecapital.com.

About CIT

CIT (NYSE: CIT) is a bank holding company with more than $60 billion in finance and leasing assets that provides financial products and advisory services to small and middle market businesses. Operating in more than 50 countries across 30 industries, CIT provides an unparalleled combination of relationship, intellectual and financial capital to its customers worldwide. CIT maintains leadership positions in small business and middle market lending, retail finance, aerospace, equipment and rail leasing, and vendor finance. Founded in 1908 and headquartered in New York City, CIT is a member of the S&P 500 and Fortune 500. www.cit.com

# # #

MEDIA RELATIONS:
C. Curtis Ritter
Director of External Communications & Media Relations
(212) 461-7711
curt.ritter@cit.com

INVESTOR RELATIONS:
Ken Brause
Executive Vice President
(212) 771-9650
ken.brause@cit.com